Silk-fibroin hydrogels, methods of forming, and uses thereof
The present disclosure provides transparent, elastic silk hydrogels for applications, including corneal reshaping to restore visual acuity and photolithography. The present disclosure also provides methods of photocrosslinking silk fibroin protein using riboflavin as a photoinitiator and exposing such riboflavin doped silk fibroin to light resulting in the formation of a transparent, elastic hydrogel.
1. A method, comprising:
providing a mixture comprising silk fibroin and a flavin compound;
contacting the mixture to corneal tissue; and
exposing the mixture to visible light to induce dityrosine crosslinks in the silk fibroin to form a silk fibroin hydrogel that adheres to the corneal tissue.
2. The method of claim 1 , wherein the step of providing the mixture comprises steps of: providing a solution comprising silk fibroin; and combining the silk fibroin solution with a solution comprising a flavin compound.
3. The method of claim 1 , wherein the mixture is an aqueous mixture.
4. The method of claim 1 , further comprising a step of selectively shaping the silk fibroin hydrogel adhered to the corneal tissue.
5. The method of claim 1 , wherein the flavin compound is riboflavin or a flavin-mononucleotide (FMN).
6. The method of claim 1 , following formation of the silk fibroin hydrogel further comprising a step of rinsing the silk fibroin hydrogel to remove residual flavin compound.
7. The method of claim 1 , wherein the visible light is in a wavelength range of about 330 nm to about 470 nm.
8. The method of claim 1 , wherein the step of exposing the mixture comprises selectively exposing the mixture to visible light to induce dityrosine crosslinks in the silk fibroin to selectively form a silk fibroin hydrogel that selectively adheres to the corneal tissue.
9. The method of claim 2 , wherein the silk fibroin solution has a concentration in a range of about 0.1 mg/mL and 15 mg/mL.
10. The method of claim 1 , wherein the silk fibroin hydrogel has at least one characteristic selected from the group consisting of:
recovers from a shear strain of at least 100% without showing an indication of a plastic deformation;
substantially transparent to wavelengths above 200 nm;
exhibits negligible absorbance above 290 nm so that it is optically clear;
recovers from a compressive strain of at least 75% without showing an indication of a plastic deformation;
a storage modulus value that is between about 50 Pa and about 100 kPa;
a tangent modulus of about 200 Pa to about 400 kPa;
configured to be injectable;
a thickness that is substantially maintained with rinsing, and
substantially adheres to corneal tissue with rinsing.